# Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients

> **NCT00121784** · PHASE4 · TERMINATED · sponsor: **Hoffmann-La Roche** · enrollment: 12 (actual)

## Conditions studied

- Heart Transplantation

## Interventions

- **DRUG:** mycophenolate mofetil [CellCept]

## Key facts

- **NCT ID:** NCT00121784
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-10
- **Primary completion:** 2006-08
- **Final completion:** 2006-08
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Poor recruitment
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00121784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00121784, "Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00121784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*